Cutting Edge Spine Announces Notice of Issuance by the United States Patent and Trademark Office of Patent No. US 11,771,482 B2: IMPLANTS FOR TISSUE FIXATION AND FUSION
Orthopedic trabecular fixation screw
This patent release further strengthens Cutting Edge Spine as the market leader in the field of trabecular fixation for orthopedic applications.
MINERAL SPRINGS, NC, October 26, 2023 / OrthoSpineNews / – Cutting Edge Spine (http://www.cuttingedgespine.com), a leader in the organic development and commercialization of “passively smart” spinal technologies, today announced the Notice of issuance of the United States Patent and Trademark Office relating to Patent No. US 11,771,482 B2: IMPLANTS FOR TISSUE FIXATION AND FUSION.
This third patent issue covering trabecular screws for all orthopedic fixations gives Cutting Edge Spine an exceptionally strong position in the market compared to the transformational fixation technology offerings that are trabecular in nature.
“Our patent position gives us the opportunity to freely develop a broad portfolio of patented trabecular fixation devices for all orthopedic applications, while at the same time confidently protecting our current and future market position.” said Randy Roof-President & CEO; Founder of Cutting Edge Spine. “Our first such 510(k) cleared spine system, the T-FIX™3DSI Joint Fusion System, was introduced to the market in late spring of this year and has quickly positioned Cutting Edge Spine as a leader in the fast-growing SI sector. fixation market.”
About the advanced spine
Founded in 2009, Cutting Edge Spine (CES) is a privately held medical device organization headquartered in Mineral Springs, NC. The company is committed to developing and commercializing patented “passive smart” orthopedic technologies that are transformative relative to clinical benefit to the patient, without driving up the cost of care.
Media contact
Randy Dak
Cutting Edge Spine LLC,
1 704-839-1916
r.roof@cuttingedgespine.com, www.cuttingedgespine.com
SOURCE Cutting Edge Spine, LLC
